Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases

Compartilhe ►

Association of Neurosurgical Resection With Development of Pachymeningeal Seeding in Patients With Brain Metastases

JAMA Oncol. Published online March 7, 2019. doi:10.1001/jamaoncol.2018.7204

 FullText

Key Points

Question  Is neurosurgical resection of brain metastases associated with unique patterns of tumor spread in the era of adjuvant stereotactic radiation?

Findings  In this cohort study of 1188 patients, those with brain metastases managed with neurosurgical resection and stereotactic radiation vs radiation alone were more likely to develop pachymeningeal seeding. Durable salvage of pachymeningeal seeding was uncommon, but a small percentage of patients achieved sustained disease control with radiotherapeutic approaches.

Meaning  Pachymeningeal seeding beyond the adjuvant stereotactic radiation field represents a substantial oncologic event in patients undergoing neurosurgical resection of a brain metastasis and warrants further evaluation in clinical studies.

Abstract

Importance  Neurosurgical resection represents an important management strategy for patients with large, symptomatic brain metastases and increasingly is followed by stereotactic radiation as opposed to whole-brain radiation. Whether neurosurgical resection is associated with tumor spread beyond the resection site and adjuvant stereotactic radiation field remains unknown.

Objective  To characterize the association and incidence of pachymeningeal seeding with neurosurgical resection in patients with brain metastases treated with adjuvant stereotactic radiation.

Design, Setting, and Participants  Retrospective cohort study of a consecutive sample of patients with newly diagnosed brain metastases managed with neurosurgical resection and stereotactic radiation (n?=?318) vs radiation alone (n?=?870) between 2001 and 2015.

Main Outcomes and Measures  Incidence of pachymeningeal seeding (dural and/or outer arachnoid) and leptomeningeal disease in patients treated with neurosurgical resection and stereotactic radiation vs radiation alone and the risk factors and outcomes associated with pachymeningeal seeding in patients treated with neurosurgical resection followed by stereotactic radiation.

Results  In 1188 patients with newly diagnosed brain metastases, 133 men and 185 women (mean [SD] age, 58.9 [11.5] years) underwent neurosurgical resection. Resection was found to be associated with pachymeningeal seeding (36 of 318 patients vs 0 of 870 patients; P?<?.001) but not leptomeningeal disease (hazard ratio [HR], 1.14; 95% CI, 0.73-1.77; P?=?.56). In total, 36 (8.4%) of 428 operations were complicated by pachymeningeal seeding, with a higher incidence noted with resection of previously irradiated vs unirradiated metastases (HR, 2.39; 95% CI, 1.25-4.57; P?=?.008). Patients with pachymeningeal seeding had relatively low rates of subsequent development of new brain metastases and leptomeningeal disease (8 [16%] of 51 and 6 [13%] of 48, respectively). Among patients with pachymeningeal seeding, neurologic death primarily owing to progressive pachymeningeal disease accounted for 26 (72%) of 36 deaths, but when treated with salvage radiation, patients survived 1 year or longer.

Conclusions and Relevance  In the era of omission of adjuvant whole-brain radiation after neurosurgical resection, pachymeningeal seeding beyond the stereotactic radiation field represents a notable oncologic event that often proves difficult to salvage. However, in some patients, disease control can be achieved with radiotherapeutic approaches.